PREPRINT (not peer reviewed)

From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PsyArXiv
Date: 2024-10-01
Source: PsyArXiv
DOI: 10.31234/osf.io/uxhv7
PubMed: Unavailable

Authors

Schenberg EE.

Watch author

Derived topics and classifications

psilocybin Depression PTSD Randomized Controlled Trial Review Article Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2The Journal of Clinical Psychiatry · 2021-02-23 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01